cabergoline - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
CABASER Cabergoline 1mg tablet bottle AUST R: 57360Active ingredients:
cabergoline
Dosage form:
Tablet, uncoated
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
From
10 Jul 2026
to
31 Aug 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
The sponsor is working to expedite the next shipment. An overseas-registered product containing cabergoline 1mg has been approved for supply under section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|
CABASER Cabergoline 2mg tablet bottle AUST R: 57367Active ingredients:
cabergoline
Dosage form:
Tablet, uncoated
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
From
20 Jul 2026
to
31 Aug 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
The sponsor is working to expedite the next shipment. An overseas-registered product containing cabergoline 1mg has been approved for supply under section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
|